Calcipotriene Prior Authorization
Customize your policy alerts
Sign up for all venturacountyhealthcareplan policy alerts
Know when venturacountyhealthcareplan releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs prior authorization coverage for topical calcipotriene products used to treat plaque psoriasis of the body or scalp. It applies to adults and, depending on formulation, pediatric patients aged 12 years and older.
The 2025 revision replaced the description of vitamin D2 with vitamin D3.
The 2025 revision modified the dosage-form section and references.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.